Clinical features of head and neck cancer patients with methicillin-resistant Staphylococcus aureus
Conclusions. The risk factors for methicillin-resistant Staphylococcus aureus (MRSA) detection in head and neck cancer patients are the duration of hospitalization, intravenous hyperalimentation, prior antibiotic use, and the coexistence of other pathogens. Objectives. To shed light on the clinical...
Gespeichert in:
| Veröffentlicht in: | Acta oto-laryngologica 2007, Vol.127 (2), p.180-185 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 185 |
|---|---|
| container_issue | 2 |
| container_start_page | 180 |
| container_title | Acta oto-laryngologica |
| container_volume | 127 |
| creator | Shiomori, Teruo Miyamoto, Hiroshi Udaka, Tsuyoshi Okochi, Jiro Hiraki, Nobuaki Hohchi, Nobusuke Hashida, Koichi Fujimura, Takeyuki Kitamura, Takuro Nagatani, Gunji Ohbuchi, Toyoaki Suzuki, Hideaki |
| description | Conclusions. The risk factors for methicillin-resistant Staphylococcus aureus (MRSA) detection in head and neck cancer patients are the duration of hospitalization, intravenous hyperalimentation, prior antibiotic use, and the coexistence of other pathogens. Objectives. To shed light on the clinical characteristics of MRSA-positive inpatients with head and neck cancers. The secondary goal was to evaluate risk factors for MRSA detection in comparison with methicillin-sensitive S. aureus (MSSA). Patients and methods. Sixty-one consecutive inpatients with head and neck cancers with S. aureus detection were analyzed based on their medical records. The antimicrobial susceptibility of isolated S. aureus was tested by the broth microdilution method. Results. MRSA and MSSA were detected in 46 (75.4%) and 15 (24.6%) of the 61 patients, respectively. There was no significant difference in the male/female ratio, age, primary site, comorbidity, cancer stage, cancer treatment, or 5-year survival rate between the MRSA and MSSA groups. Compared with the MSSA group, the MRSA group had significantly longer hospitalization periods and intervals between admission and MRSA detection, as well as significantly greater likelihood of intravenous hyperalimentation, prior antibiotic use, and co-isolation of other pathogens. Isolated strains of MRSA were thoroughly sensitive to vancomycin and arbekacin and moderately sensitive to minocycline. |
| doi_str_mv | 10.1080/00016480600750018 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_00016480600750018</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70275395</sourcerecordid><originalsourceid>FETCH-LOGICAL-c434t-2950b5decfc3da3b3cfadace1e0c5306e898803ae122d663266e932860125153</originalsourceid><addsrcrecordid>eNp9kc2KFDEURoMoTjv6AG4kG92V3lQq6RS6GRr_YMCFsy9up25RGVNJm6QY5u1N0y2DCLNKQs73kXvC2GsB7wUY-AAAQncGNMBW1b15wjZCK9G0rRJP2eZ431Sgv2Avcr49HnujnrMLsZW6kwo2zO68C86i5xNhWRNlHic-E44cw8gD2V_cYrCU-AGLo1Ayv3Nl5guV2Vnna7ypKZcLhsJ_FjzM9z7aaO2aOdbCNb9kzyb0mV6d10t28-Xzze5bc_3j6_fd1XVjO9mVpu0V7NVIdrJyRLmXdsIRLQkCqyRoMr0xIJFE245ay1Zr6mVrNIg6rpKX7N2p9pDi75VyGRaXLXmPgeKahy20WyX7IyhOoE0x50TTcEhuwXQ_CBiOYof_xNbMm3P5ul9ofEicTVbg7RnAXHVOqUpz-YEzCvq26yr36cS5MMW04F1MfhwKVmnpb0g-9o6P_8TrT_kyW0w03MY1her3kSn-AInAphc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70275395</pqid></control><display><type>article</type><title>Clinical features of head and neck cancer patients with methicillin-resistant Staphylococcus aureus</title><source>MEDLINE</source><source>Taylor & Francis Medical Library - CRKN</source><source>Taylor & Francis Journals Complete</source><creator>Shiomori, Teruo ; Miyamoto, Hiroshi ; Udaka, Tsuyoshi ; Okochi, Jiro ; Hiraki, Nobuaki ; Hohchi, Nobusuke ; Hashida, Koichi ; Fujimura, Takeyuki ; Kitamura, Takuro ; Nagatani, Gunji ; Ohbuchi, Toyoaki ; Suzuki, Hideaki</creator><creatorcontrib>Shiomori, Teruo ; Miyamoto, Hiroshi ; Udaka, Tsuyoshi ; Okochi, Jiro ; Hiraki, Nobuaki ; Hohchi, Nobusuke ; Hashida, Koichi ; Fujimura, Takeyuki ; Kitamura, Takuro ; Nagatani, Gunji ; Ohbuchi, Toyoaki ; Suzuki, Hideaki</creatorcontrib><description>Conclusions. The risk factors for methicillin-resistant Staphylococcus aureus (MRSA) detection in head and neck cancer patients are the duration of hospitalization, intravenous hyperalimentation, prior antibiotic use, and the coexistence of other pathogens. Objectives. To shed light on the clinical characteristics of MRSA-positive inpatients with head and neck cancers. The secondary goal was to evaluate risk factors for MRSA detection in comparison with methicillin-sensitive S. aureus (MSSA). Patients and methods. Sixty-one consecutive inpatients with head and neck cancers with S. aureus detection were analyzed based on their medical records. The antimicrobial susceptibility of isolated S. aureus was tested by the broth microdilution method. Results. MRSA and MSSA were detected in 46 (75.4%) and 15 (24.6%) of the 61 patients, respectively. There was no significant difference in the male/female ratio, age, primary site, comorbidity, cancer stage, cancer treatment, or 5-year survival rate between the MRSA and MSSA groups. Compared with the MSSA group, the MRSA group had significantly longer hospitalization periods and intervals between admission and MRSA detection, as well as significantly greater likelihood of intravenous hyperalimentation, prior antibiotic use, and co-isolation of other pathogens. Isolated strains of MRSA were thoroughly sensitive to vancomycin and arbekacin and moderately sensitive to minocycline.</description><identifier>ISSN: 0001-6489</identifier><identifier>EISSN: 1651-2251</identifier><identifier>DOI: 10.1080/00016480600750018</identifier><identifier>PMID: 17364350</identifier><identifier>CODEN: AOLAAJ</identifier><language>eng</language><publisher>Stockholm: Informa UK Ltd</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Anti-Infective Agents - therapeutic use ; antibiotic treatment ; Biological and medical sciences ; Female ; head and neck cancers ; Head and Neck Neoplasms - epidemiology ; Hospitalization - statistics & numerical data ; Humans ; Japan - epidemiology ; Male ; Medical sciences ; Methicillin Resistance ; Middle Aged ; MRSA ; Otorhinolaryngology (head neck, general aspects and miscellaneous) ; Otorhinolaryngology. Stomatology ; Parenteral Nutrition, Total - statistics & numerical data ; risk factor ; Risk Factors ; Staphylococcal Infections - drug therapy ; Staphylococcal Infections - epidemiology ; Staphylococcus aureus - isolation & purification ; Tumors</subject><ispartof>Acta oto-laryngologica, 2007, Vol.127 (2), p.180-185</ispartof><rights>2007 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2007</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c434t-2950b5decfc3da3b3cfadace1e0c5306e898803ae122d663266e932860125153</citedby><cites>FETCH-LOGICAL-c434t-2950b5decfc3da3b3cfadace1e0c5306e898803ae122d663266e932860125153</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1080/00016480600750018$$EPDF$$P50$$Ginformaworld$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1080/00016480600750018$$EHTML$$P50$$Ginformaworld$$H</linktohtml><link.rule.ids>314,776,780,4010,27900,27901,27902,59620,59726,60409,60515,61194,61229,61375,61410</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18509244$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17364350$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shiomori, Teruo</creatorcontrib><creatorcontrib>Miyamoto, Hiroshi</creatorcontrib><creatorcontrib>Udaka, Tsuyoshi</creatorcontrib><creatorcontrib>Okochi, Jiro</creatorcontrib><creatorcontrib>Hiraki, Nobuaki</creatorcontrib><creatorcontrib>Hohchi, Nobusuke</creatorcontrib><creatorcontrib>Hashida, Koichi</creatorcontrib><creatorcontrib>Fujimura, Takeyuki</creatorcontrib><creatorcontrib>Kitamura, Takuro</creatorcontrib><creatorcontrib>Nagatani, Gunji</creatorcontrib><creatorcontrib>Ohbuchi, Toyoaki</creatorcontrib><creatorcontrib>Suzuki, Hideaki</creatorcontrib><title>Clinical features of head and neck cancer patients with methicillin-resistant Staphylococcus aureus</title><title>Acta oto-laryngologica</title><addtitle>Acta Otolaryngol</addtitle><description>Conclusions. The risk factors for methicillin-resistant Staphylococcus aureus (MRSA) detection in head and neck cancer patients are the duration of hospitalization, intravenous hyperalimentation, prior antibiotic use, and the coexistence of other pathogens. Objectives. To shed light on the clinical characteristics of MRSA-positive inpatients with head and neck cancers. The secondary goal was to evaluate risk factors for MRSA detection in comparison with methicillin-sensitive S. aureus (MSSA). Patients and methods. Sixty-one consecutive inpatients with head and neck cancers with S. aureus detection were analyzed based on their medical records. The antimicrobial susceptibility of isolated S. aureus was tested by the broth microdilution method. Results. MRSA and MSSA were detected in 46 (75.4%) and 15 (24.6%) of the 61 patients, respectively. There was no significant difference in the male/female ratio, age, primary site, comorbidity, cancer stage, cancer treatment, or 5-year survival rate between the MRSA and MSSA groups. Compared with the MSSA group, the MRSA group had significantly longer hospitalization periods and intervals between admission and MRSA detection, as well as significantly greater likelihood of intravenous hyperalimentation, prior antibiotic use, and co-isolation of other pathogens. Isolated strains of MRSA were thoroughly sensitive to vancomycin and arbekacin and moderately sensitive to minocycline.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anti-Infective Agents - therapeutic use</subject><subject>antibiotic treatment</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>head and neck cancers</subject><subject>Head and Neck Neoplasms - epidemiology</subject><subject>Hospitalization - statistics & numerical data</subject><subject>Humans</subject><subject>Japan - epidemiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methicillin Resistance</subject><subject>Middle Aged</subject><subject>MRSA</subject><subject>Otorhinolaryngology (head neck, general aspects and miscellaneous)</subject><subject>Otorhinolaryngology. Stomatology</subject><subject>Parenteral Nutrition, Total - statistics & numerical data</subject><subject>risk factor</subject><subject>Risk Factors</subject><subject>Staphylococcal Infections - drug therapy</subject><subject>Staphylococcal Infections - epidemiology</subject><subject>Staphylococcus aureus - isolation & purification</subject><subject>Tumors</subject><issn>0001-6489</issn><issn>1651-2251</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc2KFDEURoMoTjv6AG4kG92V3lQq6RS6GRr_YMCFsy9up25RGVNJm6QY5u1N0y2DCLNKQs73kXvC2GsB7wUY-AAAQncGNMBW1b15wjZCK9G0rRJP2eZ431Sgv2Avcr49HnujnrMLsZW6kwo2zO68C86i5xNhWRNlHic-E44cw8gD2V_cYrCU-AGLo1Ayv3Nl5guV2Vnna7ypKZcLhsJ_FjzM9z7aaO2aOdbCNb9kzyb0mV6d10t28-Xzze5bc_3j6_fd1XVjO9mVpu0V7NVIdrJyRLmXdsIRLQkCqyRoMr0xIJFE245ay1Zr6mVrNIg6rpKX7N2p9pDi75VyGRaXLXmPgeKahy20WyX7IyhOoE0x50TTcEhuwXQ_CBiOYof_xNbMm3P5ul9ofEicTVbg7RnAXHVOqUpz-YEzCvq26yr36cS5MMW04F1MfhwKVmnpb0g-9o6P_8TrT_kyW0w03MY1her3kSn-AInAphc</recordid><startdate>2007</startdate><enddate>2007</enddate><creator>Shiomori, Teruo</creator><creator>Miyamoto, Hiroshi</creator><creator>Udaka, Tsuyoshi</creator><creator>Okochi, Jiro</creator><creator>Hiraki, Nobuaki</creator><creator>Hohchi, Nobusuke</creator><creator>Hashida, Koichi</creator><creator>Fujimura, Takeyuki</creator><creator>Kitamura, Takuro</creator><creator>Nagatani, Gunji</creator><creator>Ohbuchi, Toyoaki</creator><creator>Suzuki, Hideaki</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><general>Taylor and Francis</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>8BM</scope></search><sort><creationdate>2007</creationdate><title>Clinical features of head and neck cancer patients with methicillin-resistant Staphylococcus aureus</title><author>Shiomori, Teruo ; Miyamoto, Hiroshi ; Udaka, Tsuyoshi ; Okochi, Jiro ; Hiraki, Nobuaki ; Hohchi, Nobusuke ; Hashida, Koichi ; Fujimura, Takeyuki ; Kitamura, Takuro ; Nagatani, Gunji ; Ohbuchi, Toyoaki ; Suzuki, Hideaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c434t-2950b5decfc3da3b3cfadace1e0c5306e898803ae122d663266e932860125153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anti-Infective Agents - therapeutic use</topic><topic>antibiotic treatment</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>head and neck cancers</topic><topic>Head and Neck Neoplasms - epidemiology</topic><topic>Hospitalization - statistics & numerical data</topic><topic>Humans</topic><topic>Japan - epidemiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methicillin Resistance</topic><topic>Middle Aged</topic><topic>MRSA</topic><topic>Otorhinolaryngology (head neck, general aspects and miscellaneous)</topic><topic>Otorhinolaryngology. Stomatology</topic><topic>Parenteral Nutrition, Total - statistics & numerical data</topic><topic>risk factor</topic><topic>Risk Factors</topic><topic>Staphylococcal Infections - drug therapy</topic><topic>Staphylococcal Infections - epidemiology</topic><topic>Staphylococcus aureus - isolation & purification</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shiomori, Teruo</creatorcontrib><creatorcontrib>Miyamoto, Hiroshi</creatorcontrib><creatorcontrib>Udaka, Tsuyoshi</creatorcontrib><creatorcontrib>Okochi, Jiro</creatorcontrib><creatorcontrib>Hiraki, Nobuaki</creatorcontrib><creatorcontrib>Hohchi, Nobusuke</creatorcontrib><creatorcontrib>Hashida, Koichi</creatorcontrib><creatorcontrib>Fujimura, Takeyuki</creatorcontrib><creatorcontrib>Kitamura, Takuro</creatorcontrib><creatorcontrib>Nagatani, Gunji</creatorcontrib><creatorcontrib>Ohbuchi, Toyoaki</creatorcontrib><creatorcontrib>Suzuki, Hideaki</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>ComDisDome</collection><jtitle>Acta oto-laryngologica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shiomori, Teruo</au><au>Miyamoto, Hiroshi</au><au>Udaka, Tsuyoshi</au><au>Okochi, Jiro</au><au>Hiraki, Nobuaki</au><au>Hohchi, Nobusuke</au><au>Hashida, Koichi</au><au>Fujimura, Takeyuki</au><au>Kitamura, Takuro</au><au>Nagatani, Gunji</au><au>Ohbuchi, Toyoaki</au><au>Suzuki, Hideaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical features of head and neck cancer patients with methicillin-resistant Staphylococcus aureus</atitle><jtitle>Acta oto-laryngologica</jtitle><addtitle>Acta Otolaryngol</addtitle><date>2007</date><risdate>2007</risdate><volume>127</volume><issue>2</issue><spage>180</spage><epage>185</epage><pages>180-185</pages><issn>0001-6489</issn><eissn>1651-2251</eissn><coden>AOLAAJ</coden><abstract>Conclusions. The risk factors for methicillin-resistant Staphylococcus aureus (MRSA) detection in head and neck cancer patients are the duration of hospitalization, intravenous hyperalimentation, prior antibiotic use, and the coexistence of other pathogens. Objectives. To shed light on the clinical characteristics of MRSA-positive inpatients with head and neck cancers. The secondary goal was to evaluate risk factors for MRSA detection in comparison with methicillin-sensitive S. aureus (MSSA). Patients and methods. Sixty-one consecutive inpatients with head and neck cancers with S. aureus detection were analyzed based on their medical records. The antimicrobial susceptibility of isolated S. aureus was tested by the broth microdilution method. Results. MRSA and MSSA were detected in 46 (75.4%) and 15 (24.6%) of the 61 patients, respectively. There was no significant difference in the male/female ratio, age, primary site, comorbidity, cancer stage, cancer treatment, or 5-year survival rate between the MRSA and MSSA groups. Compared with the MSSA group, the MRSA group had significantly longer hospitalization periods and intervals between admission and MRSA detection, as well as significantly greater likelihood of intravenous hyperalimentation, prior antibiotic use, and co-isolation of other pathogens. Isolated strains of MRSA were thoroughly sensitive to vancomycin and arbekacin and moderately sensitive to minocycline.</abstract><cop>Stockholm</cop><pub>Informa UK Ltd</pub><pmid>17364350</pmid><doi>10.1080/00016480600750018</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0001-6489 |
| ispartof | Acta oto-laryngologica, 2007, Vol.127 (2), p.180-185 |
| issn | 0001-6489 1651-2251 |
| language | eng |
| recordid | cdi_crossref_primary_10_1080_00016480600750018 |
| source | MEDLINE; Taylor & Francis Medical Library - CRKN; Taylor & Francis Journals Complete |
| subjects | Adult Aged Aged, 80 and over Anti-Infective Agents - therapeutic use antibiotic treatment Biological and medical sciences Female head and neck cancers Head and Neck Neoplasms - epidemiology Hospitalization - statistics & numerical data Humans Japan - epidemiology Male Medical sciences Methicillin Resistance Middle Aged MRSA Otorhinolaryngology (head neck, general aspects and miscellaneous) Otorhinolaryngology. Stomatology Parenteral Nutrition, Total - statistics & numerical data risk factor Risk Factors Staphylococcal Infections - drug therapy Staphylococcal Infections - epidemiology Staphylococcus aureus - isolation & purification Tumors |
| title | Clinical features of head and neck cancer patients with methicillin-resistant Staphylococcus aureus |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T16%3A58%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20features%20of%20head%20and%20neck%20cancer%20patients%20with%20methicillin-resistant%20Staphylococcus%20aureus&rft.jtitle=Acta%20oto-laryngologica&rft.au=Shiomori,%20Teruo&rft.date=2007&rft.volume=127&rft.issue=2&rft.spage=180&rft.epage=185&rft.pages=180-185&rft.issn=0001-6489&rft.eissn=1651-2251&rft.coden=AOLAAJ&rft_id=info:doi/10.1080/00016480600750018&rft_dat=%3Cproquest_cross%3E70275395%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70275395&rft_id=info:pmid/17364350&rfr_iscdi=true |